‹ ›
MYP_093402
← PREVIOUS NEXT → BACK
Basic Information
C16- N25
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Standard
25 amino acids
C125H215N41O37
Standard
Sequence
RQLLSGIVQQQNNLLRAIEAQQHLL
Physicochemical Analysis
2884.30 Da
9.61
0.85
0.60
0.0340
-0.21
0.57
-0.04
58.90
144.40
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1316.45
-13.58
43.0
39.0
102.0
203.0
1.0
32.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0025855 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
C16(hexadecanoic acid)
None
C16(hexadecanoic acid)
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 | against cell; -cell; HXBc2 cells
0.484±0.06 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min
PaperVirus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. | Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y. | FASEB J. 2010 Nov;24(11):4196-202. | DOI:10.1096/fj.09-151704 | PMID:20605950 PMID20605950 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20605950/
RECORD: Rec_0150950 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Cathelicidin
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1
PMID20605950 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20605950/
RECORD: Rec_0255162 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
C16(hexadecanoic acid)
None
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells
0.484±0.06 μM
IC50
PMID20605950 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20605950/
RECORD: Rec_0334113 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
C16(hexadecanoic acid)
None
Bio-Activity Profile
Antimicrobial Antiviral
PMID20605950 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20605950/